4.44

1.11% -0.05

Goodrx Holdings Inc (GDRX)

Overview News Price History Option Chain Financials Why GDRX Down? Discussions Forecast

Goodrx Holdings Inc stock is traded at $4.44, with a volume of 3.23M. It is down -1.11% in the last 24 hours and up +3.02% over the past month. GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.

Previous Close:

$4.49

Open:

$4.48

24h Volume:

3.23M

Relative Volume:

2.38

Market Cap:

$1.69B

Revenue:

$775.09M

Net Income/Loss:

$-58.68M

P/E Ratio:

176.19

EPS:

0.0252

Net Cash Flow:

$64.06M

1W Performance:

-5.73%

1M Performance:

+3.02%

6M Performance:

-43.08%

1Y Performance:

-29.41%

1-Day Range:

$4.40

$4.63

1-Week Range:

$4.32

$4.755

52-Week Range:

$4.09

$9.2599

Goodrx Holdings Inc Stock (GDRX) Company Profile

Name

Goodrx Holdings Inc

Sector

Healthcare (1176)

Industry

Health Information Services (60)

Phone

(855) 268-2822

Address

2701 OLYMPIC BOULEVARD, SANTA MONICA

Employee

694

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

GDRX's Discussions on Twitter

Compare GDRX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
GDRX Goodrx Holdings Inc	4.44	1.69B	775.09M	-58.68M	64.06M	-0.1326
VEEV Veeva Systems Inc	224.15	36.39B	2.66B	665.91M	1.08B	4.05
SOLV Solventum Corp	66.83	11.55B	8.26B	66.00M	1.17B	0.3682
DOCS Doximity Inc	57.83	10.80B	516.85M	174.11M	217.38M	0.87
HQY Healthequity Inc	94.95	8.23B	1.15B	96.70M	-161.99M	1.09
WAY Waystar Holding Corp	36.82	6.34B	906.14M	-52.62M	89.62M	-0.3621

Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-04-24	Initiated	Mizuho	Neutral
Aug-09-24	Upgrade	Raymond James	Outperform → Strong Buy
May-23-24	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
May-16-24	Upgrade	Raymond James	Mkt Perform → Outperform
Apr-10-24	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Mar-25-24	Upgrade	Wells Fargo	Equal Weight → Overweight
Mar-01-24	Upgrade	JP Morgan	Neutral → Overweight
Feb-26-24	Initiated	Leerink Partners	Outperform
Jan-02-24	Downgrade	BofA Securities	Buy → Underperform
Aug-10-23	Upgrade	DA Davidson	Neutral → Buy
Jul-31-23	Upgrade	TD Cowen	Market Perform → Outperform
Dec-01-22	Initiated	Citigroup	Buy
Nov-04-22	Upgrade	JP Morgan	Underweight → Neutral
Sep-16-22	Initiated	KeyBanc Capital Markets	Sector Weight
Sep-07-22	Initiated	Truist	Hold
Aug-12-22	Initiated	DA Davidson	Neutral
Jun-10-22	Downgrade	Goldman	Buy → Neutral
Jun-06-22	Resumed	BofA Securities	Buy
Jun-01-22	Downgrade	Robert W. Baird	Outperform → Neutral
May-10-22	Downgrade	Evercore ISI	Outperform → In-line
May-10-22	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
May-10-22	Downgrade	Raymond James	Outperform → Mkt Perform
May-10-22	Downgrade	SVB Leerink	Outperform → Mkt Perform
Apr-11-22	Initiated	Wells Fargo	Equal Weight
Apr-07-22	Initiated	Guggenheim	Buy
Apr-01-22	Resumed	Credit Suisse	Neutral
Mar-15-22	Upgrade	Robert W. Baird	Neutral → Outperform
Mar-01-22	Reiterated	Barclays	Overweight
Mar-01-22	Reiterated	BofA Securities	Neutral
Mar-01-22	Downgrade	Cowen	Outperform → Market Perform
Mar-01-22	Downgrade	Credit Suisse	Outperform → Neutral
Mar-01-22	Reiterated	Evercore ISI	Outperform
Mar-01-22	Reiterated	Goldman	Buy
Mar-01-22	Reiterated	JP Morgan	Underweight
Mar-01-22	Reiterated	RBC Capital Mkts	Outperform
Mar-01-22	Reiterated	SVB Leerink	Outperform
Jan-07-22	Initiated	Goldman	Buy
Dec-21-21	Initiated	Stephens	Overweight
Dec-02-21	Initiated	Jefferies	Buy
Aug-31-21	Upgrade	Barclays	Equal Weight → Overweight
Aug-13-21	Upgrade	Raymond James	Mkt Perform → Outperform
May-28-21	Initiated	Robert W. Baird	Neutral
Apr-06-21	Resumed	Evercore ISI	Outperform
Jan-25-21	Initiated	Guggenheim	Buy
Nov-19-20	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
Nov-18-20	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Oct-19-20	Initiated	Barclays	Equal Weight
Oct-19-20	Initiated	BofA Securities	Neutral
Oct-19-20	Initiated	Citigroup	Buy
Oct-19-20	Initiated	Cowen	Outperform
Oct-19-20	Initiated	Credit Suisse	Outperform
Oct-19-20	Initiated	Deutsche Bank	Hold
Oct-19-20	Initiated	Goldman	Neutral
Oct-19-20	Initiated	JP Morgan	Neutral
Oct-19-20	Initiated	Morgan Stanley	Overweight
Oct-19-20	Initiated	RBC Capital Mkts	Sector Perform
Oct-19-20	Initiated	SVB Leerink	Outperform
Oct-19-20	Initiated	UBS	Buy

View All

Goodrx Holdings Inc Stock (GDRX) Latest News

Dec 18, 2024

GoodRx to Present at J.P. Morgan's Prestigious Healthcare Conference in January 2025 - StockTitan

Dec 18, 2024

GoodRx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire

Dec 18, 2024

GoodRx Holdings, Inc. Appoints Wendy Barnes as CEO Starting January 1, 2025 - Marketscreener.com

Dec 18, 2024

GoodRx names new CEO - The Business Journals

Dec 18, 2024

Dec 17, 2024

Morgan Stanley Has Lowered Expectations for GoodRx (NASDAQ:GDRX) Stock Price - MarketBeat

Dec 17, 2024

GoodRx Report: 70% of U.S. Counties Face Critical Endocrinologist Shortage, 50M Americans Affected - StockTitan

Dec 17, 2024

GoodRx stock rises 5% after new CEO appointment - Investing.com

Dec 17, 2024

GoodRx stock rises 5% after new CEO appointment By Investing.com - Investing.com UK

Dec 17, 2024

Dec 16, 2024

GoodRx names Wendy Barnes as new CEO and President - Investing.com

Dec 16, 2024

GoodRx Holdings Appoints Wendy Barnes as CEO - TipRanks

Dec 16, 2024

GoodRx names Wendy Barnes as new CEO and President By Investing.com - Investing.com UK

Dec 16, 2024

GoodRx Names Wendy Barnes as New CEO - MarketWatch

Dec 16, 2024

GoodRx appoints Wendy Barnes as new CEO - Investing.com

Dec 16, 2024

GoodRx Names Healthcare Veteran Wendy Barnes as New CEO to Drive Growth Strategy - StockTitan

Dec 16, 2024

Dec 15, 2024

Charles Schwab Investment Management Inc. Boosts Stake in GoodRx Holdings, Inc. (NASDAQ:GDRX) - Defense World

Dec 15, 2024

Dec 11, 2024

Fortem Financial Group LLC Takes Position in GoodRx Holdings, Inc. (NASDAQ:GDRX) - MarketBeat

Dec 11, 2024

Is GoodRx Holdings (GDRX) the Best NASDAQ Penny Stock to Buy Right Now? - Insider Monkey

Dec 11, 2024

Dec 10, 2024

11 Best NASDAQ Penny Stocks To Buy Right Now - Insider Monkey

Dec 10, 2024

GoodRx Agrees to Settle Data-Sharing Lawsuit for $25 Million - ClassAction.org

Dec 10, 2024

Dec 09, 2024

Kuehn Law Encourages Investors of GoodRx Holdings, Inc. to Contact Law Firm - The Eastern Progress Online

Dec 09, 2024

Dec 08, 2024

Pier Capital LLC Makes New $3.26 Million Investment in GoodRx Holdings, Inc. (NASDAQ:GDRX) - MarketBeat

Dec 08, 2024

Point72 Asset Management L.P. Acquires New Holdings in GoodRx Holdings, Inc. (NASDAQ:GDRX) - MarketBeat

Dec 08, 2024

Dec 02, 2024

Rubric Capital Management LP Increases Stock Holdings in GoodRx Holdings, Inc. (NASDAQ:GDRX) - MarketBeat

Nov 27, 2024

GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives $8.86 Average Price Target from Brokerages - MarketBeat

Nov 27, 2024

Nov 26, 2024

Class Action Filed Against GoodRx Holdings, Inc. (GDRX) Seeking Recovery for InvestorsContact Levi & Korsinsky - GuruFocus.com

Nov 26, 2024

Nov 25, 2024

US Penny Stocks To Consider In November 2024 - Simply Wall St

Nov 25, 2024

Nov 23, 2024

GoodRx (NASDAQ:GDRX) Trading Up 8.2%Time to Buy? - MarketBeat

Nov 23, 2024

GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares Sold by Connor Clark & Lunn Investment Management Ltd. - MarketBeat

Nov 23, 2024

Nov 19, 2024

Why GoodRx Holdings Stock Was Sinking This Week - MSN

Nov 19, 2024